Cargando…
Prevention of age-related macular degeneration
Age-related macular degeneration (AMD) is one of the leading causes of blindness in the developed world. Although effective treatment modalities such as anti-VEGF treatment have been developed for neovascular AMD, there is still no effective treatment for geographical atrophy, and therefore the most...
Autores principales: | Wong, Ian Yat Hin, Koo, Simon Chi Yan, Chan, Clement Wai Nang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021198/ https://www.ncbi.nlm.nih.gov/pubmed/20862519 http://dx.doi.org/10.1007/s10792-010-9397-5 |
Ejemplares similares
-
Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
por: Chan, Clement K., et al.
Publicado: (2023) -
Prevention of the Onset of Age-Related Macular Degeneration
por: Di Carlo, Emiliano, et al.
Publicado: (2021) -
Age-Related Macular Degeneration: What Do We Know So Far?
por: Ma, Ho Hin, et al.
Publicado: (2021) -
Nutrients for Prevention of Macular Degeneration and Eye-Related Diseases
por: Khoo, Hock Eng, et al.
Publicado: (2019) -
Peroxisome Proliferator-Activated Receptor and Age-Related Macular Degeneration
por: Herzlich, Alexandra A., et al.
Publicado: (2008)